According to DelveInsight’s analysis, the growth of the KRAS Inhibitors market is expected to be mainly driven by increasing incidence, a rise in awareness...
The global increase in cancer cases is the main factor driving the demand for supportive care drugs. Additionally, the growing incidence of adverse effects...
Nanomedicine is experiencing heightened demand, mainly propelled by the increasing occurrence of chronic ailments like cardiovascular, neurological,...
The demand for biopharmaceuticals is primarily driven by the increasing prevalence of chronic, infectious, and neurological diseases, coupled with the...
The dynamics of the intratumoral cancer therapies market are anticipated to change in the coming years owing to the approval of several drugs targeting...
/PRNewswire/ -- The cell therapy market size is expected to grow by USD 31.04 billion from 2022 to 2027. In addition, the momentum of the market will progress...
The growth of the non-small cell lung cancer market is expected to be driven by increasing incident cases of NSCLC, continued uptake of approved therapies...
/PRNewswire/ -- The hematopoietic stem cells transplantation (HSCT) market size is set to grow by USD 2383.61 million between 2023 and 2027, and register a...
Visiongain has published a new report entitled Stem Cell Technologies and Applications 2022-2032. It includes profiles of Stem Cell Technologies and...
Visiongain has published a new report entitled Stem Cell Technologies and Applications 2022-2032. It includes profiles of Stem Cell Technologies and...
/PRNewswire/ -- The "Global Stem Cells Market (2022-2027) by Product, Technology, Source, Applications, and Geography, with Competitive Analysis, Impact of...
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Feb. 11) 10X ...